tiprankstipranks
Amcor (AMCR)
NYSE:AMCR
Want to see AMCR full AI Analyst Report?

Amcor (AMCR) AI Stock Analysis

1,641 Followers

Top Page

AMCR

Amcor

(NYSE:AMCR)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
$43.00
â–²(2.53% Upside)
Action:Reiterated
Date:06/16/26
The score is driven mainly by mixed fundamentals: strong recent revenue momentum but constrained by thin/declining margins, elevated leverage, and only average cash conversion. Technicals are supportive with positive momentum, while valuation is balanced by a high dividend yield but a relatively high P/E. Earnings-call commentary adds moderate support via EPS growth and synergies, tempered by reduced free-cash-flow guidance and near-term leverage.
Positive Factors
Revenue Growth Momentum
Sustained top-line acceleration expands scale and bargaining power with large CPG and healthcare customers. Durable revenue growth supports long-term procurement leverage, capacity utilization and the ability to invest in higher‑value product development, aiding margin recovery and deleveraging over multiple quarters.
Negative Factors
Margin Compression
Material margin erosion versus prior years reduces earnings robustness and the firm’s buffer against cost shocks. Persistent thin net margins limit cash cushion, increase sensitivity to resin inflation and make long‑term profitability dependent on sustained cost saves and successful pricing pass‑through.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Momentum
Sustained top-line acceleration expands scale and bargaining power with large CPG and healthcare customers. Durable revenue growth supports long-term procurement leverage, capacity utilization and the ability to invest in higher‑value product development, aiding margin recovery and deleveraging over multiple quarters.
Read all positive factors

Amcor Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Analyzes income from different business units, highlighting which segments drive growth and profitability, and identifying areas of potential expansion or risk.
Chart InsightsThe pronounced step‑up in both Flexibles and Rigid revenues in 2025 is largely M&A‑driven rather than organic: management attributes much of the recent topline gain to the Berry combination and commercial wins, while comparable volumes remain modestly negative. That means revenue growth today masks limited near‑term operating‑leverage (comparable Flexibles EBIT barely up ex‑acquisition), one‑time integration costs and a soft non‑core pocket that still pressures margins—synergies are accelerating and should drive margin recovery over 2–3 years, but treat the revenue jump as acquisition lift, not purely organic momentum.
Data provided by:The Fly

Amcor (AMCR) vs. SPDR S&P 500 ETF (SPY)

Amcor Business Overview & Revenue Model

Company Description
Amcor plc stands as a prominent global provider of packaging solutions, focusing on the creation, production, and distribution of its diverse product portfolio across Europe, North America, Latin America, Africa, and the Asia Pacific regions. The ...
How the Company Makes Money
Amcor makes money primarily by selling packaging products and related services to business customers (B2B), typically large consumer packaged goods companies and healthcare manufacturers. Revenue is generated from (1) the manufacture and sale of f...

Amcor Earnings Call Summary

Earnings Call Date:May 06, 2026
(Q3-2026)
|
% Change Since: |
Next Earnings Date:Aug 19, 2026
Earnings Call Sentiment Neutral
The call balanced strong executional achievements — notably accelerated synergy capture, accretive acquisition benefits, EPS growth, progress on divestitures and maintained margins in the core portfolio — against near‑term operating headwinds including modest volume declines, a temporary free cash flow reduction driven by higher inventory, weather impacts and inflationary resin pressure. Management reiterated guidance, deleveraging commitment and a clear plan to convert synergies and divestiture proceeds into debt reduction, but short‑term cash and working capital timing risks temper the outlook.
Positive Updates
Synergy Delivery Ahead of Plan
Delivered ~$77M of synergies in Q3 and ~$170M year-to-date; now expect $270M in fiscal 2026 (ahead of initial $260M year‑1 target) and $650M cumulatively over 3 years.
Negative Updates
Volume Weakness
Overall volumes down approximately 1.5% in the quarter (comparable basis); core and noncore both down ~1.5%; healthcare and some nutrition subsegments were notable areas of softness.
Read all updates
Q3-2026 Updates
Negative
Synergy Delivery Ahead of Plan
Delivered ~$77M of synergies in Q3 and ~$170M year-to-date; now expect $270M in fiscal 2026 (ahead of initial $260M year‑1 target) and $650M cumulatively over 3 years.
Read all positive updates
Company Guidance
Amcor guided fiscal 2026 adjusted EPS of $3.98–$4.03 per share (midpoint implying roughly 12% full‑year EPS growth and >20% Q4 YoY growth), revised free cash flow to $1.5–$1.6 billion (down from $1.8–$1.9B due to holding higher‑cost inventory), and year‑end adjusted leverage of ~3.4–3.5x (Q3 adjusted leverage 3.8x) with a continued path to a 2.5–3.0x target; they expect $270M of synergies in FY26 (Q3 synergies $77M, $170M YTD, $650M cumulative over 3 years, with ~ $160M year‑1 procurement/G&A line‑of‑sight and ~$325M by FY28), fiscal 2026 capex of $850–$900M, and reiterated that Q3 results included revenue $5.9B, EBITDA $892M, EBIT $687M, adjusted EPS $0.96 (up 6% YoY), Q3 free cash outflow $39M (9‑month outflow $93M) and a quarterly dividend of $0.65; management said working‑capital timing is temporarily impacted by inventory decisions and should normalize as supply conditions stabilize.

Amcor Financial Statement Overview

Summary
Revenue accelerated sharply in the TTM period, but profitability is thin and has compressed versus prior years (TTM net margin ~3.1%, EBIT margin ~6.5%). Leverage is elevated (debt-to-equity ~1.43) and cash conversion is only average, with TTM FCF positive (~$1.58B) but slightly declining and below net income (~0.72x).
Income Statement
62
Positive
Balance Sheet
52
Neutral
Cash Flow
55
Neutral
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue25.52B15.01B13.64B14.69B14.54B12.86B
Gross Profit4.62B2.83B2.71B2.73B2.82B2.73B
EBITDA3.51B1.77B1.85B2.13B1.90B1.92B
Net Income874.00M511.00M730.00M1.05B805.00M939.00M
Balance Sheet
Total Assets37.58B37.07B16.52B17.00B17.43B17.19B
Cash, Cash Equivalents and Short-Term Investments1.59B827.00M588.00M689.00M775.00M850.00M
Total Debt16.71B15.01B7.19B7.21B6.98B6.75B
Total Liabilities25.92B25.33B12.57B12.91B13.29B12.37B
Stockholders Equity11.65B11.73B3.88B4.03B4.08B4.76B
Cash Flow
Free Cash Flow1.58B810.00M829.00M735.00M999.00M993.00M
Operating Cash Flow1.81B1.39B1.32B1.26B1.53B1.46B
Investing Cash Flow-2.59B-2.10B-476.00M-309.00M-527.00M-233.00M
Financing Cash Flow1.91B910.00M-857.00M-1.02B-891.00M-1.18B

Amcor Technical Analysis

Technical Analysis Sentiment
Positive
Last Price41.94
Price Trends
50DMA
38.80
Positive
100DMA
41.11
Positive
200DMA
40.48
Positive
Market Momentum
MACD
0.54
Negative
RSI
64.15
Neutral
STOCH
82.20
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMCR, the sentiment is Positive. The current price of 41.94 is above the 20-day moving average (MA) of 38.61, above the 50-day MA of 38.80, and above the 200-day MA of 40.48, indicating a bullish trend. The MACD of 0.54 indicates Negative momentum. The RSI at 64.15 is Neutral, neither overbought nor oversold. The STOCH value of 82.20 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AMCR.

Amcor Risk Analysis

Amcor disclosed 35 risk factors in its most recent earnings report. Amcor reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Amcor Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$20.49B27.4215.95%2.42%7.86%-13.88%
63
Neutral
$15.27B16.5117.29%1.53%14.00%82.84%
63
Neutral
$11.18B15.9224.33%1.01%7.06%35.16%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
61
Neutral
$19.01B28.315.80%6.20%64.83%-48.00%
55
Neutral
$23.27B63.482.08%4.21%20.90%-40.94%
46
Neutral
$19.27B-5.88-20.44%4.69%25.45%-625.24%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AMCR
Amcor
41.42
-1.19
-2.79%
BALL
Ball
58.19
3.16
5.75%
CCK
Crown Holdings
102.20
0.89
0.88%
IP
International Paper Co
36.15
-7.86
-17.87%
PKG
Packaging
229.55
47.81
26.31%
SW
Smurfit Westrock
44.05
3.42
8.42%

Amcor Corporate Events

Business Operations and StrategyExecutive/Board Changes
Amcor Announces Key Leadership Changes in Global Operations
Positive
Jun 15, 2026
On June 15, 2026, Amcor announced the retirement of Fred Stephan as Division President, Global Flexible Packaging Solutions effective June 30, 2026, with his continued service as special advisor through December 31, 2026 under a transition and ret...
Business Operations and StrategyRegulatory Filings and Compliance
Amcor Aligns Fiscal Year With Standard Calendar Reporting
Positive
May 6, 2026
On May 1, 2026, Amcor plc’s board approved a change to the company’s fiscal year, shifting from a July 1–June 30 cycle to a calendar year running January 1–December 31, and designating July 1, 2026 to December 31, 2026 as a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 16, 2026